StressCovidV1, Main, Exploration, bibRecord, 002679

Hepatitis C virus infection and injection drug users : Prevention, risk factors, and treatment

Identifieur interne : 002679 ( Main/Exploration ); précédent : 002678; suivant : 002680

Hepatitis C virus infection and injection drug users : Prevention, risk factors, and treatment

Auteurs : Markus Backmund [Allemagne] ; Jens Reimer [Allemagne] ; Kirsten Meyer [Allemagne] ; J. Tilman Gerlach [Allemagne] ; Reinhart Zachoval [Allemagne]

Source :

Clinical infectious diseases [ 1058-4838 ] ; 2005.

RBID : Pascal:05-0321842

Descripteurs français

Pascal (Inist)
- Hépatite virale C, Toxicomanie, Voie intraveineuse, Prévention, Facteur risque, Virus hépatite C, Traitement, Prévalence, Transmission, Contamination, Environnement, Dépistage, Réinfection, Stress, Substance toxicomanogène, Addiction, Travailleur social, Homme, Séroconversion.
Wicri :
- topic : Toxicomanie, Travailleur social, Homme.

English descriptors

KwdEn :
- Addiction, Contamination, Drug addiction, Drug of abuse, Environment, Hepatitis C virus, Human, Intravenous administration, Medical screening, Prevalence, Prevention, Reinfection, Risk factor, Social worker, Stress, Transmission, Treatment, Viral hepatitis C.

Abstract

Injection drug users (IDUs) are the largest group of persons infected with hepatitis C virus (HCV), with a prevalence of 50%-90%. The transmission of HCV is not the effect of the drug injected but of sharing contaminated equipment. For the sake of prevention, we have to know which factors are more likely to lead to HCV seroconversion and which particular situations and environments are risk factors for equipment sharing. As far as therapy is concerned, some studies have shown that treatment for HCV infection in IDUs during substitution treatment for drug dependency is as successful as is treatment of patients who are not IDUs. Screening and early treatment of IDUs could play an important role in controlling HCV infection. The rate of reinfection may not as high as supposed. All studies dealing with treatment for HCV infection in IDUs have stressed the necessity of collaboration among hepatologists and specialists in addiction medicine, social workers, and psychotherapists.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000245
to stream PascalFrancis, to step Curation: 000064
to stream PascalFrancis, to step Checkpoint: 000162
to stream Main, to step Merge: 002683
to stream Main, to step Curation: 002679

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Hepatitis C virus infection and injection drug users : Prevention, risk factors, and treatment</title>
<author><name sortKey="Backmund, Markus" sort="Backmund, Markus" uniqKey="Backmund M" first="Markus" last="Backmund">Markus Backmund</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Addiction Medicine, General Hospital Munich-Schwabing</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reimer, Jens" sort="Reimer, Jens" uniqKey="Reimer J" first="Jens" last="Reimer">Jens Reimer</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Centre for Interdisciplinary Addiction Research, University of Hamburg</s1>
<s2>Hamburg</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><settlement type="city">Hambourg</settlement>
<region type="land" nuts="2">Hambourg</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meyer, Kirsten" sort="Meyer, Kirsten" uniqKey="Meyer K" first="Kirsten" last="Meyer">Kirsten Meyer</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Addiction Medicine, General Hospital Munich-Schwabing</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gerlach, J Tilman" sort="Gerlach, J Tilman" uniqKey="Gerlach J" first="J. Tilman" last="Gerlach">J. Tilman Gerlach</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Medical Department II, Klinikum Grosshadern</s1>
<s2>Grosshadern</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Grosshadern</wicri:noRegion>
<wicri:noRegion>Klinikum Grosshadern</wicri:noRegion>
<wicri:noRegion>Grosshadern</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zachoval, Reinhart" sort="Zachoval, Reinhart" uniqKey="Zachoval R" first="Reinhart" last="Zachoval">Reinhart Zachoval</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Medical Department II, Klinikum Grosshadern</s1>
<s2>Grosshadern</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Grosshadern</wicri:noRegion>
<wicri:noRegion>Klinikum Grosshadern</wicri:noRegion>
<wicri:noRegion>Grosshadern</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0321842</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0321842 INIST</idno>
<idno type="RBID">Pascal:05-0321842</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000245</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000064</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000162</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000162</idno>
<idno type="wicri:doubleKey">1058-4838:2005:Backmund M:hepatitis:c:virus</idno>
<idno type="wicri:Area/Main/Merge">002683</idno>
<idno type="wicri:Area/Main/Curation">002679</idno>
<idno type="wicri:Area/Main/Exploration">002679</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Hepatitis C virus infection and injection drug users : Prevention, risk factors, and treatment</title>
<author><name sortKey="Backmund, Markus" sort="Backmund, Markus" uniqKey="Backmund M" first="Markus" last="Backmund">Markus Backmund</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Addiction Medicine, General Hospital Munich-Schwabing</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reimer, Jens" sort="Reimer, Jens" uniqKey="Reimer J" first="Jens" last="Reimer">Jens Reimer</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Centre for Interdisciplinary Addiction Research, University of Hamburg</s1>
<s2>Hamburg</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><settlement type="city">Hambourg</settlement>
<region type="land" nuts="2">Hambourg</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meyer, Kirsten" sort="Meyer, Kirsten" uniqKey="Meyer K" first="Kirsten" last="Meyer">Kirsten Meyer</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Addiction Medicine, General Hospital Munich-Schwabing</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gerlach, J Tilman" sort="Gerlach, J Tilman" uniqKey="Gerlach J" first="J. Tilman" last="Gerlach">J. Tilman Gerlach</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Medical Department II, Klinikum Grosshadern</s1>
<s2>Grosshadern</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Grosshadern</wicri:noRegion>
<wicri:noRegion>Klinikum Grosshadern</wicri:noRegion>
<wicri:noRegion>Grosshadern</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zachoval, Reinhart" sort="Zachoval, Reinhart" uniqKey="Zachoval R" first="Reinhart" last="Zachoval">Reinhart Zachoval</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Medical Department II, Klinikum Grosshadern</s1>
<s2>Grosshadern</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Grosshadern</wicri:noRegion>
<wicri:noRegion>Klinikum Grosshadern</wicri:noRegion>
<wicri:noRegion>Grosshadern</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Clinical infectious diseases</title>
<title level="j" type="abbreviated">Clin. infect. dis.</title>
<idno type="ISSN">1058-4838</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical infectious diseases</title>
<title level="j" type="abbreviated">Clin. infect. dis.</title>
<idno type="ISSN">1058-4838</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Addiction</term>
<term>Contamination</term>
<term>Drug addiction</term>
<term>Drug of abuse</term>
<term>Environment</term>
<term>Hepatitis C virus</term>
<term>Human</term>
<term>Intravenous administration</term>
<term>Medical screening</term>
<term>Prevalence</term>
<term>Prevention</term>
<term>Reinfection</term>
<term>Risk factor</term>
<term>Social worker</term>
<term>Stress</term>
<term>Transmission</term>
<term>Treatment</term>
<term>Viral hepatitis C</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Hépatite virale C</term>
<term>Toxicomanie</term>
<term>Voie intraveineuse</term>
<term>Prévention</term>
<term>Facteur risque</term>
<term>Virus hépatite C</term>
<term>Traitement</term>
<term>Prévalence</term>
<term>Transmission</term>
<term>Contamination</term>
<term>Environnement</term>
<term>Dépistage</term>
<term>Réinfection</term>
<term>Stress</term>
<term>Substance toxicomanogène</term>
<term>Addiction</term>
<term>Travailleur social</term>
<term>Homme</term>
<term>Séroconversion</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Toxicomanie</term>
<term>Travailleur social</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Injection drug users (IDUs) are the largest group of persons infected with hepatitis C virus (HCV), with a prevalence of 50%-90%. The transmission of HCV is not the effect of the drug injected but of sharing contaminated equipment. For the sake of prevention, we have to know which factors are more likely to lead to HCV seroconversion and which particular situations and environments are risk factors for equipment sharing. As far as therapy is concerned, some studies have shown that treatment for HCV infection in IDUs during substitution treatment for drug dependency is as successful as is treatment of patients who are not IDUs. Screening and early treatment of IDUs could play an important role in controlling HCV infection. The rate of reinfection may not as high as supposed. All studies dealing with treatment for HCV infection in IDUs have stressed the necessity of collaboration among hepatologists and specialists in addiction medicine, social workers, and psychotherapists.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Bavière</li>
<li>District de Haute-Bavière</li>
<li>Hambourg</li>
</region>
<settlement><li>Hambourg</li>
<li>Munich</li>
</settlement>
</list>
<tree><country name="Allemagne"><region name="Bavière"><name sortKey="Backmund, Markus" sort="Backmund, Markus" uniqKey="Backmund M" first="Markus" last="Backmund">Markus Backmund</name>
</region>
<name sortKey="Gerlach, J Tilman" sort="Gerlach, J Tilman" uniqKey="Gerlach J" first="J. Tilman" last="Gerlach">J. Tilman Gerlach</name>
<name sortKey="Meyer, Kirsten" sort="Meyer, Kirsten" uniqKey="Meyer K" first="Kirsten" last="Meyer">Kirsten Meyer</name>
<name sortKey="Reimer, Jens" sort="Reimer, Jens" uniqKey="Reimer J" first="Jens" last="Reimer">Jens Reimer</name>
<name sortKey="Zachoval, Reinhart" sort="Zachoval, Reinhart" uniqKey="Zachoval R" first="Reinhart" last="Zachoval">Reinhart Zachoval</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002679 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002679 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:05-0321842
   |texte=   Hepatitis C virus infection and injection drug users : Prevention, risk factors, and treatment
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021

	Serveur d'exploration Stress et Covid
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Stress et Covid

Hepatitis C virus infection and injection drug users : Prevention, risk factors, and treatment

Hepatitis C virus infection and injection drug users : Prevention, risk factors, and treatment

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri